Robotic pill company Rani Therapeutics (Nasdaq:RANI) has begun developing RT-111, a RaniPill GO capsule containing a biosimilar of Johnson & Johnson’s (NYSE:JNJ) Stelara (ustekinumab). The company anticipates that RT-111 could potentially treat psoriatic arthritis, ulcerative colitis, Crohn’s disease and psoriasis. The FDA first approved Stelara in 2009 for psoriasis. Stelara is available in intravenous and […]
How Dexcom uses wearables to deliver differentiated diabetes management
Dexcom (Nasdaq:DXCM) is one of the leaders in the diabetes technology space with its continuous glucose monitoring (CGM) technology. The company’s current-generation Dexcom G6 CGM remains one of the biggest players in the CGM space. Meanwhile, its next-generation Dexcom G7 CGM has already launched in a number of countries overseas. The wearable device — which […]
Dexcom launches NIL program for college athletes with diabetes
Dexcom (Nasdaq:DXCM) announced today that it launched Dexcom U, an NIL (name, image, likeness) program for college athletes. The San Diego-based company aims for the program to celebrate college athletes with diabetes. The company labeled it the first-ever NIL program designed to do so. Dexcom also hopes it inspires those with diabetes to pursue athletic […]
BD, Biocorp partner on connectivity for self-administered injectable drugs
BD (NYSE:BDX) announced that it entered into an agreement with Biocorp with the aim to use connected technology with injectable drugs. The companies seek to track adherence for self-administered drug therapies, including biologics. They plan to integrate France-based Biocorp’s Injay technology with BD’s UltraSafe Plus passive needle guard. Biocorp designed Injay to capture and transmit […]
Medtronic launches diabetes insights program for MiniMed users
Medtronic (NYSE:MDT) announced today that it introduced a new diabetes management program for users of the MiniMed 770G insulin pump. The medtech giant calls the new program My Insights. It designed it exclusively for individuals using the MiniMed 770G hybrid closed-loop insulin delivery system. Using an individual’s data, My Insight provides personalized tips, trends and […]
Ypsomed unveils new autoinjector
Ypsomed (SIX:YPSN) announced today that it developed a new autoinjector platform for liquid medications with volumes between 1.5 mL and 5.5 mL. Burgdorf, Switzerland-based Ypsomed built the YpsoMate 5.5 autoinjector on the established technology of the YpsoMate 2.25 Pro. The latest addition to the YpsoMate portfolio enables self-administration for larger-volume medications. These medications may treat […]
GlucoTrack hires former Dexcom scientist as VP of sensor technology
GlucoTrack (Nasdaq:GCTK) announced today that it appointed Mark Tapsak as its vice president of sensor technology. Tapsak, a veteran of more than 25 years in the diabetes industry, joins the company, effective immediately. His experience includes time spent as a medical device research scientist. He focused on polymer synthesis, polymer characterization, medical device design and […]
BioCorRx completes enrollment in trial of naltrexone implant for treating opioid use disorder
BioCorRx (OTC:BICX) announced today that it enrolled the last subject in the Phase I clinical trial of its BICX104 implant. Anaheim, California-based BioCorRx designed BICX104 for the treatment of opioud use disorder (OUD). Its BioCorRx Pharmaceuticals company developed the implantable, biodegradable naltrexone pellet. “We are pleased to have reached this significant milestone,” said Brady Granier, […]
Koru Medical appoints new VP of medical affairs
Koru Medical Systems (Nasdaq:KRMD) announced today that it appointed Brent Rutland as its new VP of medical affairs. Rutland joins the Mahwah, New Jersey-based drug delivery technology developer with 27 years of experience in the space. Most recently, he served as a senior director for health outcomes at La Jolla Pharmaceutical Company. Among his previous […]
Iradimed withdraws 510(k) application for MR-compatible IV pump
Iradimed (Nasadq:IRMD) announced that it voluntarily withdrew an FDA 510(k) application for its new model MR IV pump. Winter Springs, Florida-based Iradimed said it learned that the FDA likely wouldn’t have time to finish clearance activities for the pending submission. Upon learning this, the company decided to voluntarily withdraw its application on Oct. 5. The […]